UBS initiates coverage on 6 pharma stocks. Sun Pharma, Cipla among top buys

[Global brokerage firm UBS has initiated coverage on several pharma stocks, highlighting potential upsides and challenges within the sector. The report points to weakening trends in both India and the US, with underappreciated growth slowdowns in these markets. UBS has provided a mixed outlook, issuing both ‘Buy’ and ‘Sell’ ratings on a range of pharmaceutical stocks.Here is a list of 6 pharma stocks on which UBS initiated coverage:
https://img.etimg.com/thumb/msid-113759371,width-1070,height-580,overlay-etmarkets/photo.jpg
https://economictimes.indiatimes.com/markets/stocks/news/ubs-initiates-coverage-on-6-pharma-stocks-sun-pharma-cipla-among-top-buys/pharma-bets/slideshow/113759371.cms